Eukaryotic Elongation Factor 1 Complex Subunits Are Critical HIV-1 Reverse Transcription Cofactors

Total Page:16

File Type:pdf, Size:1020Kb

Eukaryotic Elongation Factor 1 Complex Subunits Are Critical HIV-1 Reverse Transcription Cofactors Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors Kylie Warrena,b,1, Ting Weia,1, Dongsheng Lia, Fangyun Qinc, David Warrilowd, Min-Hsuan Lina,e, Haran Sivakumarana, Ann Apollonia, Catherine M. Abbottf, Alun Jonesg, Jenny L. Andersonh,i, and David Harricha,2 aDepartment of Cell and Molecular Biology, Queensland Institute of Medical Research, Herston, Queensland, 4029, Australia; bSchool of Natural Sciences, University of Western Sydney, Hawkesbury, New South Wales, 2751, Australia; cGuangxi Animal Centers for Disease Control, Nanning, Guangxi 530001, People’s Republic of China; dPublic Health Virology Laboratory, Queensland Health Forensic and Scientific Services, Archerfield, Queensland, 4108, Australia; eSchool of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, 4072, Australia; fMedical Genetics Section, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom; gInstitute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, Queensland, 4072, Australia; hCentre for Virology, Burnet Institute, Melbourne, Victoria, 3004, Australia; and iDepartment of Medicine, Monash University, Melbourne, Victoria, 3004, Australia Edited by Stephen P. Goff, Columbia University College of Physicians and Surgeons, New York, NY, and approved April 18, 2012 (received for review March 23, 2012) Cellular proteins have been implicated as important for HIV-1 Attempts to purify and to identify cellular RTC cofactors by reverse transcription, but whether any are reverse transcription more conventional methods have only partly succeeded (4, 8). complex (RTC) cofactors or affect reverse transcription indirectly is Narayan et al. showed that in vitro fusion of avian sarcoma and unclear. Here we used protein fractionation combined with an leukosis virus endosomal particles required the addition of cel- endogenous reverse transcription assay to identify cellular pro- lular lysates for formation of productive RTCs, which greatly teins that stimulated late steps of reverse transcription in vitro. We increased early and late products of reverse transcription (8). identified 25 cellular proteins in an active protein fraction, and They reported that the reverse transcription enhancing activity here we show that the eEF1A and eEF1G subunits of eukaryotic was >5 kDa in mass and required ATP hydrolysis. Warrilow et al. elongation factor 1 (eEF1) are important components of the HIV-1 showed that cell lysate made from human and murine cell lines RTC. eEF1A and eEF1G were identified in fractionated human T-cell contained an activity that did not affect synthesis of -ssDNA but lysates as reverse transcription cofactors, as their removal ablated did improve late DNA synthesis by up to 30-fold (4, 9). The MICROBIOLOGY the ability of active protein fractions to stimulate late reverse stimulatory activity, isolated by size-exclusion chromatography, transcription in vitro. We observed that the p51 subunit of reverse purified with an apparent molecular mass of >20 MDa, sug- transcriptase and integrase, two subunits of the RTC, coimmuno- gesting that it was associated with a complex of molecules such precipitated with eEF1A and eEF1G. Moreover eEF1A and eEF1G as aggregated protein, DNA, or RNA. This study aimed to associated with purified RTCs and colocalized with reverse tran- identify cellular factors that stimulate reverse transcription by scriptase following infection of cells. Reverse transcription in cells chromatographic methods. was sharply down-regulated when eEF1A or eEF1G levels were Here we show that subunits of the eukaryotic elongation fac- reduced by siRNA treatment as a result of reduced levels of RTCs tor 1 (eEF1) complex are required to stimulate late stages of in treated cells. The combined evidence indicates that these eEF1 HIV-1 reverse transcription in vitro, as depletion of eEF1 sub- subunits are critical RTC stability cofactors required for efficient units eEF1A and eEF1G ablated the ability of active protein completion of reverse transcription. The identification of eEF1 sub- fractions to stimulate late steps of HIV-1 reverse transcription. units as unique RTC components provides a basis for further inves- These eEF1 subunits coimmunoprecipitate RTC proteins in fi tigations of reverse transcription and traf cking of the RTC to vitro, and following cell infection cosediment with RTCs by iso- the nucleus. pycnography and colocalize with RT as shown by proximity ligation assay. We also observed significant down-regulation of fi puri cation | mass spectrometry | cellular factor | siRNA knock down | virus reverse transcription efficiency when eEF1A and eEF1G protein replication levels were reduced by siRNA treatment that was attributed to reduced levels of RTC in infected cells. Further investigation of he HIV type-1 (HIV-1) reverse transcriptase (RT) enzyme the eEF1 and RTC interaction has implications with respect to Tcarries out reverse transcription through DNA polymerase trafficking and nuclear import of HIV reverse transcription/pre- and RNase H activities, which mediate a sequential series of steps integration complexes (PICs). that include the initiation of DNA synthesis producing negative strand strong stop DNA (−ssDNA), full-length negative-strand Results DNA, positive-strand DNA, and intact preintegrative double- Purification and Identification of Cellular Proteins in Fractions That strand DNA (reviewed elsewhere 1). The ability of HIV-1 to ef- Stimulate Reverse Transcription in Vitro. We previously confirmed ficiently produce early reverse transcription products in vitro has an activity in a partially purified cytoplasmic lysate derived from been described (2). However, under in vitro conditions, the pro- a human T cell line (Jurkat), named S100, that increased the duction of late reverse transcription products is less efficient than that observed in HIV-1–infected cells (3, 4), suggesting that host cellular factors are required. After entry into the host cell cyto- Author contributions: K.W., T.W., D.L., D.W., and D.H. designed research; K.W., T.W., D.L., plasm, the HIV-1 core, containing the viral genomic RNA, RT, F.Q., M.-H.L., and A.J. performed research; H.S., A.A., C.M.A., J.L.A., and D.H. contributed new reagents/analytic tools; K.W., T.W., D.L., D.W., M.-H.L., H.S., A.A., C.M.A., J.L.A., and and integrase (IN), reorganizes to form the reverse transcription D.H. analyzed data; and K.W., T.W., D.L., D.W., M.-H.L., H.S., A.A., C.M.A., J.L.A., and D.H. complex (RTC). The RTC requires both IN and RT to be active wrote the paper. (5), and they are believed to recruit cellular factors to facilitate The authors declare no conflict of interest. DNA synthesis (6). Although two-hybrid library and genome- This article is a PNAS Direct Submission. wide RNAi screening methods have implicated more than 50 1K.W. and T.W. contributed equally to this work. cellular proteins as important for reverse transcription (6, 7), 2To whom correspondences should be addressed. E-mail: [email protected]. whether any of these cellular proteins are RTC components, or This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. whether they direct the RTC in other ways, is unclear. 1073/pnas.1204673109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1204673109 PNAS Early Edition | 1of6 Downloaded by guest on September 26, 2021 ability of HIV-1 to generate late endogenous reverse transcrip- a peak level of eEF1A and eEF1G in fractions was coincident to tion (ERT) products in vitro (4, 9) in a concentration-dependent a peak of ERT stimulatory activity, although they were present at manner (Fig. S1A). We defined reverse transcription efficiency as reduced levels in subsequent fraction (Fig. S3). To determine the ability to synthesize late HIV-1 DNA relative to early DNA whether eEF1A or eEF1G were required for stimulatory activity, product expressed as a percentage. Starting with S100, the activity DAF was incubated with agarose beads covalently coupled to was fractionated through a CL-4B Sepharose column, where the anti–(α)-eEF1A, α-eEF1G, or α-eIF3A antibodies to reduce stimulatory activity, referred to as the “peak of gel filtration” their concentration in the unbound fraction. DAF was incubated (PGF), was detected only in fractions with a high molecular mass with BSA protein–coupled beads as a control. Western blot (9). Next, 1 mg PGF protein was applied to a DEAE anion-ex- analysis of treated DAF showed that the levels of the respective change column that resulted in isolation of reverse transcription proteins were reduced by ∼90%, 70%, and 95%, respectively stimulatory activity in very few fractions (Fig. 1), and will be (Fig. 2A). The activity of the depleted DAFs was tested using hereafter referred to as “DEAE active fraction” (DAF). SDS/ in vitro ERT reactions in parallel with control reactions con- PAGE analysis of DAF revealed well-defined, Coomassie-stained taining intact DAF or no added protein (i.e., buffer only). Fig. 2B protein bands (Fig. S1B) that were excised, digested with trypsin, shows that depletion of eEF1A and eEF1G, but not eIF3A, and subjected to liquid chromatography–mass spectrometry (LC- resulted in sharply reduced reverse transcription efficiency in MS/MS) analysis. The protein purification and MS-identification ERT. In all experiments (n = 4), a complete loss of reverse process was repeated four times, and 25 host proteins were iden- transcription stimulatory activity was observed when eEF1G tified in at least three of the four experiments (Table S1). levels were reduced by 70–90%, whereas it was reduced by three- The identified proteins fall into six broad function classes: to fourfold when eEF1A was depleted by 90–95% (Fig. 2B). translation factors, transcription regulators, synthetases, mRNA eEF2 was refractory to immunodepletion with the available splicing/transport factors, folding/transport proteins, and cellular antibodies. An increase in reverse transcription efficiency ob- organization cytoskeleton proteins. Of particular interest was the served in these reactions compared with Fig.
Recommended publications
  • University of California, San Diego
    UNIVERSITY OF CALIFORNIA, SAN DIEGO The post-terminal differentiation fate of RNAs revealed by next-generation sequencing A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Gloria Kuo Lefkowitz Committee in Charge: Professor Benjamin D. Yu, Chair Professor Richard Gallo Professor Bruce A. Hamilton Professor Miles F. Wilkinson Professor Eugene Yeo 2012 Copyright Gloria Kuo Lefkowitz, 2012 All rights reserved. The Dissertation of Gloria Kuo Lefkowitz is approved, and it is acceptable in quality and form for publication on microfilm and electronically: __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ Chair University of California, San Diego 2012 iii DEDICATION Ma and Ba, for your early indulgence and support. Matt and James, for choosing more practical callings. Roy, my love, for patiently sharing the ups and downs of this journey. iv EPIGRAPH It is foolish to tear one's hair in grief, as though sorrow would be made less by baldness. ~Cicero v TABLE OF CONTENTS Signature Page .............................................................................................................. iii Dedication ....................................................................................................................
    [Show full text]
  • Dissertation Philip Böhler
    Three Tales of Death: New Pathways in the Induction, Inhibition and Execution of Apoptosis Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Philip Böhler aus Bonn Düsseldorf, Juni 2019 aus dem Institut für Molekulare Medizin I der Heinrich-Heine-Universität Düsseldorf Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Berichterstatter: 1. Prof. Dr. Sebastian Wesselborg 2. Prof. Dr. Henrike Heise Tag der mündlichen Prüfung: 29. Oktober 2019 “Where the first primal cell was, there was I also. Where man is, there am I. When the last life crawls under freezing stars, there will I be.” — DEATH, in: Mort, by Terry Pratchett “Right away I found out something about biology: it was very easy to find a question that was very interesting, and that nobody knew the answer to.” — Richard Feynman, in: Surely You're Joking, Mr. Feynman! Acknowledgements (Danksagung) Acknowledgements (Danksagung) Viele Menschen haben zum Gelingen meiner Forschungsarbeit und dieser Dissertation beigetragen, und nicht alle können hier namentlich erwähnt werden. Dennoch möchte ich einige besonders hervorheben. An erster Stelle möchte ich Professor Sebastian Wesselborg danken, der diese Dissertation als Erstgutachter betreut hat und der mir die Möglichkeit gab, die dazugehörigen experimentellen Arbeiten am Institut für Molekulare Medizin durchzuführen. Er und Professor Björn Stork, dem ich für die herzliche Aufnahme in seine Arbeitsgruppe danke, legten durch die richtige Mischung aus aktiver Förderung und dem Freiraum zur Umsetzung eigener wissenschaftlicher Ideen die ideale Grundlage für die Forschungsprojekte, aus denen diese Dissertation entstand. Professorin Henrike Heise, die sich freundlicherweise zur Betreuung dieser Dissertation als Zweitgutachterin bereiterklärt hat, gilt ebenfalls mein herzlicher Dank.
    [Show full text]
  • EEF1D Mouse Monoclonal Antibody [Clone ID: OTI4B9] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for CF811676 EEF1D Mouse Monoclonal Antibody [Clone ID: OTI4B9] Product data: Product Type: Primary Antibodies Clone Name: OTI4B9 Applications: IHC, WB Recommended Dilution: WB 1:500~2000, IHC 1:2000 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG1 Clonality: Monoclonal Immunogen: Full length human recombinant protein of human EEF1D (NP_115754) produced in E.coli. Formulation: Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) Reconstitution Method: For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Gene Name: Homo sapiens eukaryotic translation elongation factor 1 delta (EEF1D), transcript variant 1, mRNA. Database Link: NP_115754 Entrez Gene 1936 Human P29692 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 EEF1D Mouse Monoclonal Antibody [Clone ID: OTI4B9] – CF811676 Background: This gene encodes a subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome.
    [Show full text]
  • Evolution of Translation EF-Tu: Trna
    University of Illinois at Urbana-Champaign Luthey-Schulten Group NIH Resource for Macromolecular Modeling and Bioinformatics Computational Biophysics Workshop Evolution of Translation EF-Tu: tRNA VMD Developer: John Stone MultiSeq Developers Tutorial Authors Elijah Roberts Ke Chen John Eargle John Eargle Dan Wright Zhaleh Ghaemi Jonathan Lai Zan Luthey-Schulten August 2014 A current version of this tutorial is available at http://www.scs.illinois.edu/~schulten/tutorials/ef-tu CONTENTS 2 Contents 1 Introduction 3 1.1 The Elongation Factor Tu . 3 1.2 Getting Started . 4 1.2.1 Requirements . 4 1.2.2 Copying the tutorial files . 4 1.2.3 Working directory . 4 1.2.4 Preferences . 4 1.3 Configuring BLAST for MultiSeq . 5 2 Comparative Analysis of EF-Tu 5 2.1 Finding archaeal EF1A sequences . 6 2.2 Aligning archaeal sequences and removing redundancy . 8 2.3 Finding bacteria EF-Tu sequences . 11 2.4 Performing ClustalW Multiple Sequence and Profile-Profile Align- ments . 12 2.5 Creating Multiple Sequence with MAFFT . 16 2.6 Conservation of EF-Tu among the Bacteria . 16 2.7 Finding conserved residues across the bacterial and archaeal do- mains . 20 2.8 EF-Tu Interface with the Ribosome . 21 3 Computing a Maximum Likelihood Phylogenetic Tree with RAxML 23 3.1 Load the Phylogenetic Tree into MultiSeq . 25 3.2 Reroot and Manipulate the Phylogenetic Tree . 25 4 MultiSeq TCL Scripting: Genomic Context 27 5 Appendix A 30 5.1 Building a BLAST Database . 30 6 Appendix B 31 6.1 Saving QR subset of alignments in PHYLIP and FASTA format 31 6.2 Calculating Maximum Likelihood Trees with RAxML .
    [Show full text]
  • Characterization of the Matrix Proteins of the Fish Rhabdovirus, Infectious Hematopoietic Necrosis Virus
    AN ABSTRACT OF THE THESIS OF Patricia A. Ormonde for the degree of Master of Science presented on April 14. 1995. Title: Characterization of the Matrix Proteins of the Fish Rhabdovinis, Infectious Hematopoietic Necrosis Virus. Redacted for Privacy Abstract approved: Jo-Ann C. ong Infectious hematopoietic necrosis virus (1HNV) is an important fish pathogen enzootic in salmon and trout populations of the Pacific Northwestern United States. Occasional epizootics in fish hatcheries can result in devastating losses of fish stocks. The complete nucleotide sequence of IHNV has not yet been determined. This knowledge is the first step towards understanding the roles viral proteins play in IHNV infection, and is necessary for determining the relatedness of IHNV to other rhabdoviruses. The glycoprotein, nucleocapsid and non-virion genes of IHNV have been described previously; however, at the initiation of this study, very little was known about the matrix protein genes. Rhabdoviral matrix proteins have been found to be important in viral transcription and virion assembly. This thesis describes the preliminary characterization of the M1 and M2 matrix proteins of IHNV. In addition, the trout humoral immune response to M1 and M2 proteins expressed from plasmid DNA injected into the fish was investigated. This work may prove useful in designing future vaccines against IHN. The sequences of M1 phosphoprotein and M2 matrix protein genes of IHNV were determined from both genomic and mRNA clones. Analysis of the sequences indicated that the predicted open reading frame of M1 gene encoded a 230 amino acid protein with a estimated molecular weight of 25.6 kDa. Further analysis revealed a second open reading frame encoding a 42 amino acid protein with a calculated molecular weight of 4.8 kDa.
    [Show full text]
  • Structural Characterization of the Human Eukaryotic Initiation Factor 3 Protein Complex by Mass Spectrometry*□S
    Supplemental Material can be found at: http://www.mcponline.org/cgi/content/full/M600399-MCP200 /DC1 Research Structural Characterization of the Human Eukaryotic Initiation Factor 3 Protein Complex by Mass Spectrometry*□S Eugen Damoc‡, Christopher S. Fraser§, Min Zhou¶, Hortense Videler¶, Greg L. Mayeurʈ, John W. B. Hersheyʈ, Jennifer A. Doudna§, Carol V. Robinson¶**, and Julie A. Leary‡ ‡‡ Protein synthesis in mammalian cells requires initiation The initiation phase of eukaryotic protein synthesis involves factor eIF3, an ϳ800-kDa protein complex that plays a formation of an 80 S ribosomal complex containing the initi- Downloaded from central role in binding of initiator methionyl-tRNA and ator methionyl-tRNAi bound to the initiation codon in the mRNA to the 40 S ribosomal subunit to form the 48 S mRNA. This is a multistep process promoted by proteins initiation complex. The eIF3 complex also prevents pre- called eukaryotic initiation factors (eIFs).1 Currently at least 12 mature association of the 40 and 60 S ribosomal subunits eIFs, composed of at least 29 distinct subunits, have been and interacts with other initiation factors involved in start identified (1). Mammalian eIF3, the largest initiation factor, is a codon selection. The molecular mechanisms by which multisubunit complex with an apparent molecular mass of www.mcponline.org eIF3 exerts these functions are poorly understood. Since ϳ800 kDa. This protein complex plays an essential role in its initial characterization in the 1970s, the exact size, translation by binding directly to the 40 S ribosomal subunit composition, and post-translational modifications of and promoting formation of the 43 S preinitiation complex ⅐ ⅐ mammalian eIF3 have not been rigorously determined.
    [Show full text]
  • Journal of Virology
    JOURNAL OF VIROLOGY Volume 80 March 2006 No. 6 SPOTLIGHT Articles of Significant Interest Selected from This Issue by 2587–2588 the Editors STRUCTURE AND ASSEMBLY Crystal Structure of the Oligomerization Domain of the Haitao Ding, Todd J. Green, 2808–2814 Phosphoprotein of Vesicular Stomatitis Virus Shanyun Lu, and Ming Luo Subcellular Localization of Hepatitis C Virus Structural Yves Rouille´, Franc¸ois Helle, David 2832–2841 Proteins in a Cell Culture System That Efficiently Replicates Delgrange, Philippe Roingeard, the Virus Ce´cile Voisset, Emmanuelle Blanchard, Sandrine Belouzard, Jane McKeating, Arvind H. Patel, Geert Maertens, Takaji Wakita, Czeslaw Wychowski, and Jean Dubuisson A Small Loop in the Capsid Protein of Moloney Murine Marcy R. Auerbach, Kristy R. 2884–2893 Leukemia Virus Controls Assembly of Spherical Cores Brown, Artem Kaplan, Denise de Las Nueces, and Ila R. Singh Identification of the Nucleocapsid, Tegument, and Envelope Jyh-Ming Tsai, Han-Ching Wang, 3021–3029 Proteins of the Shrimp White Spot Syndrome Virus Virion Jiann-Horng Leu, Andrew H.-J. Wang, Ying Zhuang, Peter J. Walker, Guang-Hsiung Kou, and Chu-Fang Lo GENOME REPLICATION AND REGULATION OF VIRAL GENE EXPRESSION Epitope Mapping of Herpes Simplex Virus Type 2 gH/gL Tina M. Cairns, Marie S. Shaner, Yi 2596–2608 Defines Distinct Antigenic Sites, Including Some Associated Zuo, Manuel Ponce-de-Leon, with Biological Function Isabelle Baribaud, Roselyn J. Eisenberg, Gary H. Cohen, and J. Charles Whitbeck The ␣-TIF (VP16) Homologue (ETIF) of Equine Jens von Einem, Daniel 2609–2620 Herpesvirus 1 Is Essential for Secondary Envelopment Schumacher, Dennis J. O’Callaghan, and Virus Egress and Nikolaus Osterrieder Suppression of Viral RNA Recombination by a Host Chi-Ping Cheng, Elena Serviene, 2631–2640 Exoribonuclease and Peter D.
    [Show full text]
  • Viral Strategies to Arrest Host Mrna Nuclear Export
    Viruses 2013, 5, 1824-1849; doi:10.3390/v5071824 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Nuclear Imprisonment: Viral Strategies to Arrest Host mRNA Nuclear Export Sharon K. Kuss *, Miguel A. Mata, Liang Zhang and Beatriz M. A. Fontoura Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; E-Mails: [email protected] (M.A.M.); [email protected] (L.Z.); [email protected] (B.M.A.F) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-214-633-2001; Fax: +1-214-648-5814. Received: 10 June 2013; in revised form: 27 June 2013 / Accepted: 11 July 2013 / Published: 18 July 2013 Abstract: Viruses possess many strategies to impair host cellular responses to infection. Nuclear export of host messenger RNAs (mRNA) that encode antiviral factors is critical for antiviral protein production and control of viral infections. Several viruses have evolved sophisticated strategies to inhibit nuclear export of host mRNAs, including targeting mRNA export factors and nucleoporins to compromise their roles in nucleo-cytoplasmic trafficking of cellular mRNA. Here, we present a review of research focused on suppression of host mRNA nuclear export by viruses, including influenza A virus and vesicular stomatitis virus, and the impact of this viral suppression on host antiviral responses. Keywords: virus; influenza virus; vesicular stomatitis virus; VSV; NS1; matrix protein; nuclear export; nucleo-cytoplasmic trafficking; mRNA export; NXF1; TAP; CRM1; Rae1 1. Introduction Nucleo-cytoplasmic trafficking of proteins and RNA is critical for proper cellular functions and survival.
    [Show full text]
  • The Retromer Is Co-Opted to Deliver Lipid Enzymes for the Biogenesis of Lipid-Enriched Tombusviral Replication Organelles
    The retromer is co-opted to deliver lipid enzymes for the biogenesis of lipid-enriched tombusviral replication organelles Zhike Fenga, Jun-ichi Inabaa, and Peter D. Nagya,1 aDepartment of Plant Pathology, University of Kentucky, Lexington, KY 40546 Edited by George E. Bruening, University of California, Davis, CA, and approved November 5, 2020 (received for review July 29, 2020) Biogenesis of viral replication organelles (VROs) is critical for repli- TBSV infections include extensive membrane contact sites (vMCSs) cation of positive-strand RNA viruses. In this work, we demonstrate and harbor numerous spherules (containing VRCs), which are that tomato bushy stunt virus (TBSV) and the closely related carna- vesicle-like invaginations in the peroxisomal membranes (8, 11–13). tion Italian ringspot virus (CIRV) hijack the retromer to facilitate A major gap in our understanding of the biogenesis of VROs, in- building VROs in the surrogate host yeast and in plants. Depletion cluding vMCSs and VRCs, is how the cellular lipid-modifying en- of retromer proteins, which are needed for biogenesis of endosomal zymes are recruited to the sites of viral replication. tubular transport carriers, strongly inhibits the peroxisome-associ- Tombusviruses belong to the large Flavivirus-like supergroup ated TBSV and the mitochondria-associated CIRV replication in yeast that includes important human, animal, and plant pathogens. in planta. and In vitro reconstitution revealed the need for the ret- Tombusviruses have a small single-component (+)RNA genome romer for the full activity of the viral replicase. The viral p33 repli- of ∼4.8 kb that codes for five proteins. Among those, there are cation protein interacts with the retromer complex, including Vps26, two essential replication proteins, namely p33 and p92pol, the Vps29, and Vps35.
    [Show full text]
  • Synthesis and Processing of the Transmembrane Envelope Protein of Equine Infectious Anemia Virus NANCY R
    JOURNAL OF VIROLOGY, Aug. 1990, p. 3770-3778 Vol. 64, No. 8 0022-538X/90/083770-09$02.00/0 Copyright C 1990, American Society for Microbiology Synthesis and Processing of the Transmembrane Envelope Protein of Equine Infectious Anemia Virus NANCY R. RICE,'* LOUIS E. HENDERSON,' RAYMOND C. SOWDER,1 TERRY D. COPELAND,' STEPHEN OROSZLAN,1 AND JOHN F. EDWARDS2 Laboratory of Molecular Virology and Carcinogenesis, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21701,1 and Department of Veterinary Pathology, College of Veterinary Medicine, Texas A&M University, College Station, Texas 778432 Received 22 December 1989/Accepted 10 May 1990 Downloaded from The transmembrane (TM) envelope protein of lentiviruses, including equine infectious anemia virus (EIAV), is significantly larger than that of other retroviruses and may extend in the C-terminal direction 100 to 200 amino acids beyond the TM domain. This size difference suggests a lentivirus-specific function for the long C-terminal extension. We have investigated the synthesis and processing of the EIAV TM protein by immune precipitation and immunoblotting experiments, by using several envelope-specific peptide antisera. We show that the TM protein in EIAV particles is cleaved by proteolysis to an N-terminal glycosylated 32- to 35-kilodalton (kDa) segment and a C-terminal nonglycosylated 20-kDa segment. The 20-kDa fragment was isolated from virus fractionated by high-pressure liquid chromatography, and its N-terminal amino acid sequence was determined for 13 residues. Together with the known nucleotide sequence, this fixes the cleavage http://jvi.asm.org/ site at a His-Leu bond located 240 amino acids from the N terminus of the TM protein.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Allosteric Collaboration Between Elongation Factor G and the Ribosomal L1 Stalk Directs Trna Movements During Translation
    Allosteric collaboration between elongation factor G and the ribosomal L1 stalk directs tRNA movements during translation Jingyi Feia, Jonathan E. Bronsona, Jake M. Hofmanb,1, Rathi L. Srinivasc, Chris H. Wigginsd and Ruben L. Gonzalez, Jr.a,2 aDepartment of Chemistry, bDepartment of Physics, cThe Fu Foundation School of Engineering and Applied Science and dDepartment of Applied Physics and Applied Mathematics, Columbia University, New York, NY 10027 1Current address: Yahoo! Research, 111 West 40th Street, 17th Floor, NewYork, NY 10018 2To whom correspondence may be addressed. E-mail: [email protected] Classification: Biological Sciences, Biochemistry ABSTRACT Determining the mechanism by which transfer RNAs (tRNAs) rapidly and precisely transit through the ribosomal A, P and E sites during translation remains a major goal in the study of protein synthesis. Here, we report the real-time dynamics of the L1 stalk, a structural element of the large ribosomal subunit that is implicated in directing tRNA movements during translation. Within pre-translocation ribosomal complexes, the L1 stalk exists in a dynamic equilibrium between open and closed conformations. Binding of elongation factor G (EF-G) shifts this equilibrium towards the closed conformation through one of at least two distinct kinetic mechanisms, where the identity of the P-site tRNA dictates the kinetic route that is taken. Within post-translocation complexes, L1 stalk dynamics are dependent on the presence and identity of the E-site tRNA. Collectively, our data demonstrate that EF-G and the L1 stalk allosterically collaborate to direct tRNA translocation from the P to the E sites, and suggest a model for the release of E-site tRNA.
    [Show full text]